Statements (50)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:healthcare_organization
|
gptkbp:affects |
breast tissue
|
gptkbp:associated_with |
BRC A1 mutation
BRC A2 mutation |
gptkbp:can_metastasize_to |
liver
lungs bones lymph nodes |
gptkbp:caused_by |
pain
changes in breast shape nipple discharge |
gptkbp:has_spectral_type |
invasive carcinoma
lobular carcinoma |
https://www.w3.org/2000/01/rdf-schema#label |
invasive lobular carcinoma
|
gptkbp:is_characterized_by |
small, non-cohesive cells
|
gptkbp:is_effective_against |
gptkb:triple-negative_breast_cancer
HE R2-positive breast cancer |
gptkbp:is_linked_to |
family history of breast cancer
estrogen exposure |
gptkbp:is_often_associated_with |
gptkb:invasive_ductal_carcinoma
|
gptkbp:is_often_compared_to |
gptkb:invasive_ductal_carcinoma
bilateral diagnosed at later stages |
gptkbp:is_often_gifted |
multifocality
bilateral involvement |
gptkbp:is_often_used_in |
gptkb:philosopher
older women |
gptkbp:recognizes |
gptkb:MRI
ultrasound mammography |
gptkbp:requires |
lumpectomy
mastectomy oncology consultation pathology review sentinel node biopsy |
gptkbp:risk_factor |
age
genetic mutations hormonal factors |
gptkbp:social_responsibility |
biopsy
variable prognosis |
gptkbp:symptoms |
breast lump
thickening of breast tissue |
gptkbp:treatment |
gptkb:hospital
clinical trials radiation therapy chemotherapy targeted therapy hormonal therapy |
gptkbp:type_of |
gptkb:healthcare_organization
malignant neoplasm |